BRIM Biotechnology Competitors and Similar CompaniesClear all
BRIM Biotechnology's competitors and similar companies include TriSalus Life Sciences, CHUGAI PHARMA FRANCE, NATCO Pharma and XNK Therapeutics.
 BRIM Biotechnology BRIM Biotechnology (全福生物科技股份有限公司) is a company that develops drugs for oncology and infectious disease. |  TriSalus Life Sciences TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors. |  NATCO Pharma NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API). |  XNK Therapeutics XNK Therapeutics (formerly CellProtect Nordic Pharmaceuticals) is a pharmaceutical company developing cell-based therapies for the treatment of severe diseases. | ||
Founding Date | Founding Date 2013 | Founding Date 2009 | Founding Date 1998 | Founding Date 1981 | Founding Date 2013 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Taipei, TW HQ | Locations Westminster, US HQ Bannockburn, US Cranston, US | Locations Paris, FR HQ | Locations Hyderabad, IN HQ Central Hope Town, IN Chennai, IN Hyderabad, IN Santola, IN Vijayapuri North, IN | Locations Huddinge, SE HQ |
Employees | Employees 12 | Employees 106 | Employees 73 | Employees 4,016 | Employees 9 |
Financial | |||||
Revenue (est.) | Revenue (est.) NT$5.5m (FY, 2025) | Revenue (est.) $45.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹44.1b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods NT$4.2m (FY, 2025) | Cost of goods $7m (FY, 2025) | Cost of goods N/A | Cost of goods ₹7.5b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit NT$1.3m (FY, 2025) | Gross profit $38.2m (FY, 2025) | Gross profit N/A | Gross profit ₹37b (FY, 2025) | Gross profit N/A |
Net income | Net income (NT$450.9m) (FY, 2025) | Net income ($39.2m) (FY, 2025) | Net income N/A | Net income ₹18.8b (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
TriSalus Life Sciences
HQ
Westminster, US
Employees
106
TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors.
View company
CHUGAI PHARMA FRANCE
HQ
Paris, FR
CHUGAI PHARMA FRANCE is a company that specializes in pharmaceutical products.
View companyNATCO Pharma
HQ
Hyderabad, IN
Employees
4,016
NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).
View companyXNK Therapeutics
HQ
Huddinge, SE
Employees
9
XNK Therapeutics (formerly CellProtect Nordic Pharmaceuticals) is a pharmaceutical company developing cell-based therapies for the treatment of severe diseases.
View company